VIVO CAPITAL
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
VIVO CAPITAL
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
(650) 688-0818
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
Carson Capital
Carson Capital is an investment firm that is looking to build something special and help steward a business’ growth into the future.
Johnson & Johnson Innovation – JJDC
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Optum Ventures
Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges.
Pangaea Ventures
Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
SR One
SR One is the corporate venture capital arm of GlaxoSmithKline.
SS&C Technologies
SS&C is a global provider of investment and financial software-enabled services and software focused exclusively on the global financial
TCG Crossover
TCG Crossover is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies.
Valor Capital Group
Valor is an investment firm that focuses on cross-border financial and investment opportunities.
Valor Equity Partners
Valor Equity Partners is an operational growth investment firm that focuses on growth companies across various stages of development.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-08 | Serán Bioscience | Serán Bioscience acquired by Vivo Capital | N/A |
| 2016-12-19 | Angiotech Pharmaceuticals | Angiotech Pharmaceuticals acquired by Vivo Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-30 | Celcuity | Vivo Capital investment in Post-IPO Equity - Celcuity | 60 M USD |
| 2024-05-13 | Ajax Therapeutics | Vivo Capital investment in Series C - Ajax Therapeutics | 95 M USD |
| 2024-05-07 | Zenas BioPharma | Vivo Capital investment in Series C - Zenas BioPharma | 200 M USD |
| 2024-05-03 | Abeona Therapeutics | Vivo Capital investment in Post-IPO Equity - Abeona Therapeutics | 75 M USD |
| 2024-03-20 | Clasp Therapeutics | Vivo Capital investment in Series A - Clasp Therapeutics | 150 M USD |
| 2024-03-19 | Geron | Vivo Capital investment in Post-IPO Equity - Geron | 150 M USD |
| 2024-03-14 | Unicycive Therapeutics | Vivo Capital investment in Post-IPO Equity - Unicycive Therapeutics | 50 M USD |
| 2024-03-12 | Regulus Therapeutics | Vivo Capital investment in Post-IPO Equity - Regulus Therapeutics | 100 M USD |
| 2024-02-06 | Attralus | Vivo Capital investment in Series B - Attralus | 56 M USD |
| 2024-02-05 | Adverum Biotechnologies | Vivo Capital investment in Post-IPO Equity - Adverum Biotechnologies | 127.5 M USD |
Newest Events participated
More informations about "Vivo Capital"
Vivo Capital - Healthcare Focused Investment Firm
We are a global healthcare specialist, with a multi-strategy investment platform covering venture capital, private equity and public equity strategies. We seek to support the expansion of …See details»
Vivo Capital - Wikipedia
Vivo Capital ("Vivo") is an American investment firm headquartered in Palo Alto, California. It is focused on making public and private investments in the healthcare and biotechnology industries. See details»
Our Team – Vivo Capital | Healthcare Focused …
The Vivo team has a blend of experience in scientific prowess, strategic operations, macro understanding and financial acumen.See details»
About – Vivo Capital | Healthcare Focused Investment …
Jun 19, 2014 · Vivo is a global healthcare investment platform that has dedicated strategies spanning from venture capital, private equity and public equity. We seek to foster innovation and growth in the global healthcare market via our …See details»
Vivo Capital - Crunchbase Investor Profile & Investments
Vivo Capital invests in early to late-stage biotechnology and healthcare companies, focusing on the United States, particularly in New York, San Diego, and Cambridge. Learn MoreSee details»
Vivo Capital - Org Chart, Teams, Culture & Jobs - The Org
Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $4.3 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in …See details»
Vivo Capital - Investments, Portfolio & Company Exits - Crunchbase
Vivo Capital 's most notable exits include Legend Biotech, Poseida Therapeutics, and IO Biotech. Vivo Capital has acquired 2 organizations. Their most recent acquisition was Serán Bioscience …See details»
Vivo Capital Appoints New Managing Partners and Partners
PALO ALTO, Calif., Jan. 11, 2021 /PRNewswire/ -- Vivo Capital, LLC, a leading global healthcare investment firm, is pleased to announce the appointments of Dr. Hongbo Lu, Mr. Jack Bech …See details»
Vivo Capital - Funding, Financials, Valuation & Investors
Vivo Capital has raised a total of $5.4B across 8 funds, their latest being Healthcare-Focused Investment Fund. This fund was announced on Oct 30, 2019 and raised a total of.See details»
Serán BioScience Announces $200 Million Strategic Growth …
Founded in 1996, Vivo Capital is a leading global healthcare investment firm with a diverse, multi-strategy investment platform covering venture capital, growth equity, buyout, and public …See details»
Vivo Capital Closes $1.43 Billion Fund IX to Invest in
PALO ALTO, Calif., Oct. 30, 2019 /CNW/ -- Vivo Capital, a healthcare investment firm, announced the final closing of Vivo Capital Fund IX, L.P. (the "Fund") at $1.43 billion in committed...See details»
Healthcare Focused Investment Firm - Vivo Capital
Jun 19, 2014 · Vivo Capital’s private equity strategy is focused particularly on underwriting the operational and commercial scale-up of companies with attractive growth prospects.See details»
Vivo Capital's Leadership Team - Team members and org chart
Vivo Capital's Leadership Team includes Priscilla Sugianto and 25 others.See details»
InnoCare Brings On Hillhouse as Strategic Investor, Vivo Capital ...
Beijing, Feb. 3, 2021 —— InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today two subscription agreements with Gaoling and YHG, a company …See details»
Chloe Zhang - Principal at Vivo Capital - The Org
Chloe managed a portfolio with highest AUM of HK$ 4.5 Billion with investments across mezzanine debt, share-pledged financing, privatization, cross border M&A and pre-IPO. Chloe …See details»
List of top Vivo Capital Portfolio Companies - Crunchbase
Jul 8, 2008 · Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM. This list of organizations invested in by Vivo Capital provides data on their funding …See details»
All In for Community | Vivo Expansion
All In for Community is a campaign to raise the remaining 1% of funds required for Vivo’s expansion – an 135,000 square foot, $62 million project that will unite all ages, abilities and …See details»
Reports - Vivo
Vivo’s annual reports provide information on our mission and history and summarize our impact in the past year. These reports include audited financial statements, and achievements such as …See details»
Vivo Capital - Contacts, Employees, Board Members ... - Crunchbase
Vivo Capital has 28 current employee profiles, including Managing Partner Shan Fu.See details»
Vivo – Vivo Capital | Healthcare Focused Investment Firm
Jun 19, 2014 · In August 2023, Vivo Capital, as a co-lead investor, successfully completed the A-round financing settlement with Wuhan Createrna Science and Technology Co., Ltd. …See details»